InvestorsHub Logo

nokomis

07/28/15 11:23 AM

#1107 RE: nokomis #1105

ABEO. Soros and another increasing stake. Bullish 9:04 am Abeona Therapeutics announces a direct placement of ~1.55 mln shares of registered common stock, at $5.50/share, with Soros Fund Management & Perceptive Life Science Fund groups (ABEO) : Co announced it had entered into a definitive purchase agreements with two healthcare institutional investors, Soros Fund Management and Perceptive Life Science Fund, and two Members of the Board of Directors, to raise $8.5 million in a direct placement of registered common stock.

The financing is comprised of 1,547,273 shares of common stock at a price of $5.50 per share.
Co plans to use the proceeds of the financing for the development of its proprietary rare disease programs, working capital and general corporate purposes.